News Archives

December 31, 2022

CLL Society’s COVID-19 Update for the Week of January 2, 2023

Here is your weekly summary of what has been happening this past week of January 2, 2023 in the United States.

December 29, 2022

What Makes Being Diagnosed with CLL So Surprising

Dr. Koffman was interviewed by Prevention magazine to share some of his emotional experiences when he was diagnosed with chronic lymphocytic leukemia in 2005 and what he learned that helped him cope, primarily through the early part of his journey when he was asked to “Watch and Wait.” The

December 29, 2022

ASH 2022: Dr. Jennifer Brown on Zanubrutinib vs. Ibrutinib for Relapsed/Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Leukemia (CLL / SLL)

In this interview, Dr. Brian Koffman interviewed Dr. Jennifer Brown, Director of the CLL Center at Dana-Farber Cancer Institute and Professor of Medicine at Harvard Medical School. They discussed the ALPINE trial, a phase 3 clinical trial directly comparing the efficacy of zanubrutinib vs. ibrutinib in patients with relapsed/refractory

December 26, 2022

The CLL Nurse’s Note: Common Questions and Answers About the Most Recent COVID-19 Testing Recommendations

Right now, perhaps more than at any other point in the pandemic, testing early, testing often, and testing with the correct type of test is critically important.

December 26, 2022

CLL Society’s COVID-19 Update for the Week of December 26, 2022

CLL Society’s COVID-19 Update for the Week of December 26, 2022: You all know the drill at this point! If you are eligible and have not yet received your COVID-19 bivalent booster, please consider obtaining it as soon as possible. If you have known exposure to COVID-19 or are

December 19, 2022

CLL Society’s COVID-19 Update for the Week of December 19, 2022

Before getting into the numbers this week, we want to briefly touch upon the subject of Evusheld. Many in the CLL / SLL community have been asking CLL Society why the FDA has not yet made the decision to pull the emergency use authorization (EUA) for Evusheld, just as they did

December 15, 2022

Deep Dive into Five Webcast / Podcast: Playing CLL / SLL Chess: Planning Your Therapy Moves

Join CLL Society and Dr. Matthew Davids to take a deep dive into different BTKi’s, how they work, how they compare to each other

December 12, 2022

CLL Society’s COVID-19 Update for the Week of December 12th, 2022

CLL Society’s COVID-19 Update for the Week of December 12th, 2022: The update for this week will be abbreviated due to CLL Society staff attending ASH. Numbers have sharply increased this past week and the dominant variants that are not sensitive to Evusheld continue to dominant the variant landscape.

December 6, 2022

MEI Pharma and Kyowa Kirin Announce Discontinuation of Zandelisib Development Outside of Japan Following Recent FDA Meeting

Zandelisib joins umbralisib in the parade of PI3K inhibitors that won’t be developed as an option for chronic lymphocytic leukemia/ small lymphocytic lymphoma (CLL / SLL) patients that have run out of options.

Cookie	Duration	Description
cookielawinfo-checkbox-analytics	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
cookielawinfo-checkbox-functional	11 months	The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
cookielawinfo-checkbox-necessary	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-others	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
cookielawinfo-checkbox-performance	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
viewed_cookie_policy	11 months	The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.

News

CLL Society’s COVID-19 Update for the Week of January 2, 2023

What Makes Being Diagnosed with CLL So Surprising

ASH 2022: Dr. Jennifer Brown on Zanubrutinib vs. Ibrutinib for Relapsed/Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Leukemia (CLL / SLL)

The CLL Nurse’s Note: Common Questions and Answers About the Most Recent COVID-19 Testing Recommendations

CLL Society’s COVID-19 Update for the Week of December 26, 2022

CLL Society’s COVID-19 Update for the Week of December 19, 2022

Deep Dive into Five Webcast / Podcast: Playing CLL / SLL Chess: Planning Your Therapy Moves

CLL Society’s COVID-19 Update for the Week of December 12th, 2022

MEI Pharma and Kyowa Kirin Announce Discontinuation of Zandelisib Development Outside of Japan Following Recent FDA Meeting

CLL SOCIETY FAST FIND

QUICK LINKS

ABOUT CLL SOCIETY

CONTACT